These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25518415)

  • 1. [Cyclosporin A treatment for refractory Kawasaki disease].
    Suzuki H; Suenaga T; Kakimoto N; Takeuchi T; Shibuta S
    Nihon Rinsho; 2014 Sep; 72(9):1636-40. PubMed ID: 25518415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin.
    Suzuki H; Terai M; Hamada H; Honda T; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Onouchi Y; Sasago K; Suzuki Y; Hata A
    Pediatr Infect Dis J; 2011 Oct; 30(10):871-6. PubMed ID: 21587094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
    Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
    Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.
    Onouchi Y; Gunji T; Burns JC; Shimizu C; Newburger JW; Yashiro M; Nakamura Y; Yanagawa H; Wakui K; Fukushima Y; Kishi F; Hamamoto K; Terai M; Sato Y; Ouchi K; Saji T; Nariai A; Kaburagi Y; Yoshikawa T; Suzuki K; Tanaka T; Nagai T; Cho H; Fujino A; Sekine A; Nakamichi R; Tsunoda T; Kawasaki T; Nakamura Y; Hata A
    Nat Genet; 2008 Jan; 40(1):35-42. PubMed ID: 18084290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITPKC susceptibility in Kawasaki syndrome as a sensitizing factor for autoimmunity and coronary arterial wall relaxation induced by thimerosal's effects on calcium signaling via IP3.
    Yeter D; Deth R
    Autoimmun Rev; 2012 Oct; 11(12):903-8. PubMed ID: 22498790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant.
    Okada S; Azuma Y; Suzuki Y; Yamada H; Wakabayashi-Takahara M; Korenaga Y; Akase H; Hasegawa S; Ohga S
    Pediatr Int; 2016 Apr; 58(4):295-8. PubMed ID: 26670024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.
    Peng Q; Chen C; Zhang Y; He H; Wu Q; Liao J; Li B; Luo C; Hu X; Zheng Z; Yang Y
    Pediatr Cardiol; 2012 Oct; 33(7):1046-53. PubMed ID: 22361738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytokines in Kawasaki disease].
    Abe J
    Nihon Rinsho; 2014 Sep; 72(9):1548-53. PubMed ID: 25518401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
    Raman V; Kim J; Sharkey A; Chatila T
    Pediatr Infect Dis J; 2001 Jun; 20(6):635-7. PubMed ID: 11419513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.
    Tremoulet AH; Pancoast P; Franco A; Bujold M; Shimizu C; Onouchi Y; Tamamoto A; Erdem G; Dodd D; Burns JC
    J Pediatr; 2012 Sep; 161(3):506-512.e1. PubMed ID: 22484354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine.
    Hata A; Onouchi Y
    J Hum Genet; 2009 Feb; 54(2):67-73. PubMed ID: 19158812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
    Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implication of the C Allele of the ITPKC Gene SNP rs28493229 in Kawasaki Disease: Association With Disease Susceptibility and BCG Scar Reactivation.
    Lin MT; Wang JK; Yeh JI; Sun LC; Chen PL; Wu JF; Chang CC; Lee WL; Shen CT; Wang NK; Wu CS; Yeh SZ; Chen CA; Chiu SN; Wu MH
    Pediatr Infect Dis J; 2011 Feb; 30(2):148-52. PubMed ID: 20805785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of Kawasaki disease.
    Onouchi Y
    Pediatr Res; 2009 May; 65(5 Pt 2):46R-54R. PubMed ID: 19190534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of susceptibility genes for Kawasaki disease.
    Onouchi Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):73-80. PubMed ID: 20453442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease.
    Hirono K; Kemmotsu Y; Wittkowski H; Foell D; Saito K; Ibuki K; Watanabe K; Watanabe S; Uese K; Kanegane H; Origasa H; Ichida F; Roth J; Miyawaki T; Saji T
    Pediatr Res; 2009 Jun; 65(6):696-701. PubMed ID: 19430379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect.
    Kuijpers TW; Biezeveld M; Achterhuis A; Kuipers I; Lam J; Hack CE; Becker AE; van der Wal AC
    Pediatrics; 2003 Oct; 112(4):986-92. PubMed ID: 14523200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.